Kim, Beom-Jun
Koh, Jung-Min http://orcid.org/0000-0002-7987-3677
Funding for this research was provided by:
Ministry of Health and Welfare (HI15C2792, HI15C0377)
Korea National Research Foundation (2016M3A9E8941329)
Article History
Received: 15 October 2018
Revised: 14 November 2018
Accepted: 26 November 2018
First Online: 4 December 2018
Compliance with ethical standards
:
: The authors declare that they have patents on S1P as a biomarker and SLIT3 as a therapeutic target for osteoporosis.